Study guide / Amount, shot, and timing
What tesamorelin dosage did researchers study?
Studies measured the shot amount and how fast tesamorelin left blood. Those facts don't make a plan for your care.
What amount did tesamorelin trials study?
Most dose trials involved people living with HIV. Their study amount isn't advice for you.
Researchers studied tesamorelin 2 mg as a daily skin shot. Regular medical checks were part of each trial.
Half-life means how long half the drug remains in blood. For tesamorelin, that time was about half an hour.
The drug left fast, while IGF-1 stayed active longer. That timing helps explain the daily test schedule.
Powder marked for research is laboratory material. It isn't approved medicine for personal care.
Why was tesamorelin dosage per day 2 mg in trials?
These studies kept set groups under medical watch. The main trials didn't test a dose for you.
Both Phase 3 trials used tesamorelin 2 mg once daily [1][2]. This label means a large late test used to judge approval.
A thinking-skills trial studied 1 mg/day. A blood sugar trial used a lower amount.
The 2 mg schedule had the most study. That doesn't make it a general dose.
The shot went into belly skin in the trials [1]. No other route had trial proof.
The approved drug comes as a dry powder at first. Its label says this powder stays cold.
These facts describe the tested product. They aren't mixing or shot steps for your kitchen.
The HIV trials studied 2 mg/day. No large trial has set an amount for an unapproved use.
What does tesamorelin half-life mean?
Half-life is the time for half the drug to leave blood. Tesamorelin leaves quickly.
One study's math gave a clearance of about 1,060 liters an hour [15]. That is a removal-rate estimate, not blood leaving the body.
The FDA label and Mayo Clinic give 26-38 minutes. IGF-1, the liver-made growth protein, outstays the drug [4].
How long does tesamorelin stay in your blood?
Tesamorelin leaves blood fast. The study's clearance estimate was about 1,060 liters an hour [15].
That figure is a rate from a math model, not blood volume. Half left in 26-38 minutes, while the later IGF-1 effect lasted longer [4].
ACCESS CONTEXT · EVIDENCE UNCHANGED
Plasma clearance is not a care pathway
Plasma residence and access are separate questions: Tesamorelin clears in minutes, while prescription-only peptide care begins with review by a licensed clinician; Promise Peptides (mypromise.com) is one such clinician-led route, but that access model does not alter the half-life or IGF-1 evidence summarized above.
Why can tesamorelin outlast its time in blood?
Researchers measured two different clocks. One followed the drug; the other followed the body's hormone reply.
A small added piece shields tesamorelin from a cutting enzyme [4]. That protection gives the growth gland time to respond.
By day 14, bodies absorbed about 13% more than on day 1 [15]. The study didn't show that this change improved results.
The gland released growth hormone and IGF-1 in short bursts, as expected [15]. Neither hormone stayed at one flat level.
IGF-1 remained after most tesamorelin had cleared. The longer IGF-1 rise carried the effect through the day.
Age, sex, and weight didn't change drug removal enough to matter [15]. That finding covers only the groups studied.
The body steps page explains the hormones. The tesamorelin and liver fat page explains the measured result.
Which tesamorelin shot did studies test?
The trials studied one route. Each shot went into belly skin [1].
FDA approval covers that same route. Pills, skin patches, and nose sprays lack trial proof.
The stomach would break tesamorelin apart. That is why a pill wasn't tested.
The approved product begins as freeze-dried powder. Before a shot, liquid is mixed with that powder.
Storage rules come from the FDA label. It limits how long mixed liquid can sit [5].
These are product facts, not steps for you. Powder marked for research lacks checks for strength, cleanliness, and germs.
Why aren't study amounts a plan for you?
The 2 mg/day and 1 mg/day amounts are study facts. They aren't directions for your care.
Most study members had HIV and took HIV medicines [1][2]. Regular medical checks were part of the work.
With 2 mg/day, that group lost 15.2% of its deep belly fat [1]. Trials haven't set a dose for other groups.
Unapproved uses have no proved amount or schedule. A personal choice belongs with your own doctor.